CoChat

Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors

Open access
Tong, Ricky T., Boucher, Yves, Kozin, Sergey V., Winkler, Frank, Hicklin, Daniel J., Jain, Rakesh K. · 2004 · Cancer Research

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Elevated interstitial fluid pressure, a hallmark of solid tumors, can compromise the delivery of therapeutics to tumors. Here we show that blocking vascular endothelial growth factor (VEGF) signaling by DC101 (a VEGF-receptor-2 antibody) decreases interstitial fluid pressure, not by restoring lymphatic function, but by producing a morphologically and functionally “normalized” vascular network. We demonstrate that the normalization process prunes immature vessels and improves the integrity and function of the remaining vasculature by enhancing the perivascular cell and basement membrane coverage. We also show that DC101 induces a hydrostatic pressure gradient across the vascular wall, which leads to a deeper penetration of molecules into tumors. Thus, vascular normalization may contribute to the improved survival rates in tumor-bearing animals and in colorectal carcinoma patients treated with an anti-VEGF antibody in combination with cytotoxic therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-04-0074

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 1

  1. Parker JC, Perry MA, Taylor AE. Permeability of the microvascular barrier Staub NC Taylor AE eds. . Edema, p. 143-87, Raven Press New York 1984.

Cited by

See all 1,189

Metadata

Authors
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K.
Affiliations
  • Harvard University (US)
  • 3ImClone Systems, Incorporated, New York, New York
Venue
Cancer Research
Published
2004-06-01
Volume
64
Issue
11
Pages
3731-3736
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W1977887541
Cited by
1,189
References
30
Citations by year
2026: 20 · 2025: 30 · 2024: 28 · 2023: 56 · 2022: 38 · 2021: 51 · 2020: 48 · 2019: 55 · 2018: 45 · 2017: 59 · 2016: 58 · 2015: 49 · 2014: 47 · 2013: 60 · 2012: 84
FWCI
21.00
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Science Foundation
  • National Cancer Institute (P01CA080124, P01-CA-80124)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
vascular normalization, VEGF receptor 2, DC101, anti-VEGF antibody, interstitial fluid pressure, tumor vasculature, hydrostatic pressure gradient, drug penetration, tumor microenvironment, basement membrane, perivascular cells, colorectal cancer, combination therapy
MeSH terms
Animals, Antibodies, Capillary Permeability, Humans, Hydrostatic Pressure, Neoplasms, Neovascularization, Pathologic, Serum Albumin, Bovine, Mice, SCID, Vascular Endothelial Growth Factor Receptor-2, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-0074
The paper
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004). Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-0074

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.